机器学习影像组学能否在术前鉴别混合型肝细胞-胆管细胞癌与肝细胞癌及胆管细胞癌以辅助优化治疗决策?
本回顾性研究纳入85例患者86个经组织病理学证实的肝癌(24个混合型肝细胞-胆管细胞癌、24个胆管细胞癌、38个肝细胞癌),利用MRI和CT影像组学特征结合支持向量机分类器进行术前鉴别。MRI影像组学特征在鉴别混合型肝细胞-胆管细胞癌与非混合型肝细胞-胆管细胞癌时表现最佳(AUC 0.77),而CT价值有限;MRI和CT影像组学在鉴别肝细胞癌与非肝细胞癌时表现良好。放射科医生读片将混合型肝细胞-胆管细胞癌误诊为肝细胞癌或胆管细胞癌的比例在CT为69%、MRI为58%。
要点
- MRI影像组学鉴别混合型肝细胞-胆管细胞癌与非混合型肝细胞-胆管细胞癌的AUC为0.77(SD 0.19),CT价值有限。
- MRI对比增强期相及CT平扫和门静脉期鉴别肝细胞癌与非肝细胞癌的AUC为0.71-0.81。
- 放射科医生读片误诊混合型肝细胞-胆管细胞癌为肝细胞癌或胆管细胞癌的比例CT为69%、MRI为58%。
核心结论
- MRI和CT影像组学特征结合机器学习分析在鉴别混合型肝细胞-胆管细胞癌与肝细胞癌及胆管细胞癌方面显示出有前景的预测性能,可能对治疗决策有潜在意义。
研究设计与样本
- 回顾性研究纳入85例患者(年龄32至86岁)共86个经组织病理学证实的肝癌(24个混合型肝细胞-胆管细胞癌、24个胆管细胞癌、38个肝细胞癌),患者于2004年至2018年间接受MRI和CT检查;采用PyRadiomics库提取1419个影像组学特征,经主成分分析降至20个主成分,使用支持向量机分类器评估MRI和CT影像组学特征;以组织病理学为参考标准,并评估初始CT报告和MRI形态学特征的放射科医生读片性能。
诊断标准与关键数值
- MRI影像组学特征鉴别混合型肝细胞-胆管细胞癌与非混合型肝细胞-胆管细胞癌的AUC最高为0.77(SD 0.19);CT价值有限;MRI对比增强期相鉴别肝细胞癌与非肝细胞癌的AUC为0.79(SD 0.07)至0.81(SD 0.13);CT平扫和门静脉期鉴别肝细胞癌与非肝细胞癌的AUC分别为0.81(SD 0.06)和0.71(SD 0.15);放射科医生读片误诊混合型肝细胞-胆管细胞癌为肝细胞癌或胆管细胞癌的比例CT为69%、MRI为58%。
临床应用与阅片要点
- 作者认为MRI和CT影像组学特征结合机器学习分析在鉴别混合型肝细胞-胆管细胞癌与肝细胞癌及胆管细胞癌方面显示出有前景的预测性能,可能对治疗决策有潜在意义;经未来验证后,影像组学分析有潜力为混合型肝细胞-胆管细胞癌的术前诊断提供信息,并有助于优化肝切除和肝移植的治疗决策。
局限性
- 本文为回顾性研究;原文指出经未来验证后影像组学分析才有潜力用于混合型肝细胞-胆管细胞癌的术前诊断并辅助治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To differentiate combined hepatocellular cholangiocarcinoma (cHCC-CC) from cholangiocarcinoma (CC) and hepatocellular carcinoma (HCC) using machine learning on MRI and CT radiomics features.
METHODS: This retrospective study included 85 patients aged 32 to 86 years with 86 histopathology-proven liver cancers: 24 cHCC-CC, 24 CC, and 38 HCC who had MRI and CT between 2004 and 2018. Initial CT reports and morphological evaluation of MRI features were used to assess the performance of radiologists read. Following tumor segmentation, 1419 radiomics features were extracted using PyRadiomics library and reduced to 20 principle components by principal component analysis. Support vector machine classifier was utilized to evaluate MRI and CT radiomics features for the prediction of cHCC-CC vs. non-cHCC-CC and HCC vs. non-HCC. Histopathology was the reference standard for all tumors.
RESULTS: Radiomics MRI features demonstrated the best performance for differentiation of cHCC-CC from non-cHCC-CC with the highest AUC of 0.77 (SD 0.19) while CT was of limited value. Contrast-enhanced MRI phases and pre-contrast and portal-phase CT showed excellent performance for the differentiation of HCC from non-HCC (AUC of 0.79 (SD 0.07) to 0.81 (SD 0.13) for MRI and AUC of 0.81 (SD 0.06) and 0.71 (SD 0.15) for CT phases, respectively). The misdiagnosis of cHCC-CC as HCC or CC using radiologists read was 69% for CT and 58% for MRI.
CONCLUSIONS: Our results demonstrate promising predictive performance of MRI and CT radiomics features using machine learning analysis for differentiation of cHCC-CC from HCC and CC with potential implications for treatment decisions.
KEY POINTS: • Retrospective study demonstrated promising predictive performance of MRI radiomics features in the differentiation of cHCC-CC from HCC and CC and of CT radiomics features in the differentiation of HCC from cHCC-CC and CC. • With future validation, radiomics analysis has the potential to inform current clinical practice for the pre-operative diagnosis of cHCC-CC and to enable optimal treatment decisions regards liver resection and transplantation.
引用
- Liu X, Khalvati F, Namdar K, et al. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur Radiol. 2020. PMID: 32749585. doi:10.1007/s00330-020-07119-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。